Technology
Health
Biotechnology

IVERIC

$1.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.91%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IVERIC and other stocks, options, ETFs, and crypto commission-free!

About ISEE

IVERIC bio, Inc. Common Stock, also called IVERIC, is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Read More Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.

Employees
35
Headquarters
New York, New York
Founded
2007
Market Cap
45.30M
Price-Earnings Ratio
0.70
Dividend Yield
Average Volume
58.02K
High Today
$1.13
Low Today
$1.09
Open Price
$1.09
Volume
24.67K
52 Week High
$2.60
52 Week Low
$1.02

Collections

Technology
Health
Biotechnology
Therapy
Biopharmaceutical
Pharmaceutical
2013 IPO
US

ISEE Earnings

-$0.55
-$0.45
-$0.36
-$0.26
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.